A new lab drug reaches the brain and hits glioma cells
Original title: Discovery and Optimization of a Novel Brain-Penetrant Colchicine-Binding Site Ligand for Treatment of Glioma.
How far along is this research?
- Lab cells
- Animals
- Review
- Tested in people
This was done in animals, not people. Most findings at this stage never become treatments.
This was only tested in the lab and in glioma: A tumor that starts in the glial cells. Those are the support cells of the brain and spinal cord. Gliomas are given a grade from 1 to 4. The grade says how the tumor is expected to act. See the glossary models, not in people.
The short version
Scientists built a new drug that gets into the brain and attacks glioma: A tumor that starts in the glial cells. Those are the support cells of the brain and spinal cord. Gliomas are given a grade from 1 to 4. The grade says how the tumor is expected to act. See the glossary cells in lab tests.
What was studied. Researchers designed and tested many versions of a new drug. They checked how each one sticks to a cell protein called tubulin.
What they found. The drug binds to tubulin at the same spot as a chemical called colchicine. This breaks apart the tiny support beams inside cells. One version, called compound 40, was picked to move forward. It was strong, got into the brain at moderate levels, and worked in glioma: A tumor that starts in the glial cells. Those are the support cells of the brain and spinal cord. Gliomas are given a grade from 1 to 4. The grade says how the tumor is expected to act. See the glossary models.
What this means, and what it doesn't
What it could mean: Brain tumors have very few approved drugs. temozolomide: A chemotherapy taken as a capsule, used for some brain tumors. Your team checks your blood counts while you are on it. See the glossary and vorasidenib: A medicine approved in 2024 for some people with a grade 2 glioma. The glioma has to have an IDH change. The medicine acts on that change itself. It is taken after surgery. See the glossary are the only approved pills that reach the brain. Work like this looks for another option for the future.
What it doesn't mean: This is early lab work, not care you can get. No person has taken this drug yet. Its safety in people is unknown. Many drugs that work in the lab fail later in people. This is not a cure, and not a promise of one.
Source: PubMed, October 22, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.